Letter: is blindly stopping thiopurines without confirming adequate anti-TNF concentrations shortsighted?

被引：1
|
作者：
Sousa Freitas Queiroz, Natalia [1 ]
Papamichael, Konstantinos [2 ,3 ]
Cheifetz, Adam S. [2 ,3 ]
机构：
[1] Santa Cruz Hosp, Curitiba, Parana, Brazil
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 07期
关键词：
COMBINATION THERAPY; INFLIXIMAB; AZATHIOPRINE; WITHDRAWAL;
D O I：
10.1111/apt.16819
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：887 / 888
页数：2
相关论文
共 19 条
  • [1] Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies
    Beigel, Florian
    Steinborn, Anni
    Schnitzler, Fabian
    Tillack, Cornelia
    Breiteneicher, Simone
    John, Jestinah Mahachie
    Van Steen, Kristel
    Laubender, Ruediger P.
    Goeke, Burkhard
    Seiderer, Julia
    Brand, Stephan
    Ochsenkuehn, Thomas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (07) : 735 - 744
  • [2] Are Thiopurines and Anti-TNFα Agents Safe to Use in Pregnant Patients With Inflammatory Bowel Disease?
    Sheibani, Sarah
    Mahadevan, Uma
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (03): : 441 - 443
  • [3] Letter: anti-TNF in steroid-dependent ulcerative colitis - are the available data enough?
    Barreiro-de Acosta, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (01) : 102 - 102
  • [4] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
    Rakowsky, Shana
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1049 - 1050
  • [5] In uteroexposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark
    Norgard, Bente Mertz
    Nielsen, Jan
    Friedman, Sonia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 829 - 842
  • [6] Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials
    Beelen, Evelien M. J.
    Nieboer, Daan
    Arkenbosch, Jeanine H. C.
    Regueiro, Miguel D.
    Satsangi, Jack
    Ardizzone, Sandro
    Lopez-Sanroman, Antonio
    Savarino, Edoardo
    Armuzzi, Alessandro
    van der Woude, C. Janneke
    de Vries, Annemarie C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (12) : 2741 - +
  • [7] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD? Authors' reply
    Roblin, Xavier
    Paul, Stephane
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1051 - 1051
  • [8] Systematic review: the use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance-progress and prospects
    Jones, G. R.
    Kennedy, N. A.
    Lees, C. W.
    Arnott, I. D.
    Satsangi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1253 - 1265
  • [9] Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs - a new 'therapeutic package'?
    Barreiro-de Acosta, M.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 297 - 298
  • [10] Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    CURRENT DRUG METABOLISM, 2011, 12 (06) : 594 - 598
12